Skip to main content
Clinical Trials/IRCT201507226135N5
IRCT201507226135N5
Completed
未知

To evaluate the safety and efficacy of M3D Fractional - Made By Medaria in reducing facial aging: A single arm phase III clinical trial

Medaria Company0 sites15 target enrollmentTBD
ConditionsFacial aging.

Overview

Phase
未知
Intervention
Not specified
Conditions
Facial aging.
Sponsor
Medaria Company
Enrollment
15
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medaria Company

Eligibility Criteria

Inclusion Criteria

  • Aged between 30 to 60 years.
  • Mild to moderate (Glogaue Score)
  • Skin Type (II\-IV)
  • Signed informed consent voluntarily and knowingly
  • Exclusion criteria
  • History of any implant in face area
  • History of any cosmetic surgery during last 3 years in face area
  • History of RF during last year
  • History of any Botulinum, laser, or intense pulsed light during last 6 month
  • History of Isotretinoin during last 6 month

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials